DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30

BRIGHT MINDS BIOSCIENCES INC.

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025

$53.82+2.52 (+4.91%)

Close on Oct 19, 2026

BRIGHT MINDS BIOSCIENCES INC. revenue by segment

Bright Minds Biosciences does not break out revenue by segment, region or product in the tagged data of its filings for this period type.